RecruitingNCT05499182

Latino Teen Depression Treatment Study

Identification of Implementation Strategies to Promote Depression Treatment Use Among Latino Adolescents


Sponsor

Duke University

Enrollment

35 participants

Start Date

Oct 13, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Despite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. are significantly less likely than their non-Latino White peers to receive treatment for MDD (SAMHSA, 2019). The purpose of this study is to identify a stakeholder-preferred implementation strategy that may improve psychotherapy attendance among Latino adolescents. Latino adolescent-parent dyads and healthcare providers will be recruited from healthcare settings and social media. Focus groups will be conducted with healthcare providers (n=5), and individual interviews will be conducted with Latino adolescents with a diagnosis of depression (n=15) and their parents (n=15).


Eligibility

Min Age: 13 Years

Inclusion Criteria8

  • Male gender
  • Aged 13-17 years
  • Diagnosed with Major Depressive Disorder or Persistent Depressive Disorder
  • Referred to psychotherapy and/or prescribed antidepressant medications for depression
  • Parent or legal guardian of teen
  • Able to read and speak English or Spanish
  • Self-identification as regularly providing clinical care to Latino adolescents with depression
  • Be in a role in which they can provide or refer patients to depression treatment

Exclusion Criteria4

  • Experiencing imminent thoughts of self-harm or suicide
  • Experiencing acute psychological distress (e.g., uncontrolled crying)
  • Unable to read/speak English or Spanish
  • Unable to provide or refer to depression treatment

Locations(1)

Researchmatch.org

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05499182


Related Trials